Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

November 30, 2011 — In patients with diabetes mellitus (DM) and chronic kidney disease (CKD), hemoglobin A 1c (HbA 1c) targets that fall between 7% and 9% may be associated with decreased risk for ...

Although both sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and ...

People with diabetes have a higher risk of many different health issues, including kidney and heart problems. Although various medicines can help reduce the risk of these issues, many people with ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

About one in eight women with gestational diabetes had evidence of kidney dysfunction at 5 months postpartum, according to ...

Individuals diagnosed with type 2 diabetes (T2D) between age 18-39 years had a higher risk for renal complications than individuals of the same age without T2D; however, this association decreased as ...

(HealthDay News) — For black Americans with diabetes, chronic kidney disease (CKD) appears to increase the risk of cardiovascular mortality, according to a study published online in the Clinical ...